News & Updates

Show Multimedia Only

Prenatal phthalate exposure may stunt infant growth

11 Jun 2022

Exposure to phthalates while still in the womb is associated with lower body mass index (BMI) z-scores in children, suggesting impaired growth, reports a recent meta-analysis. Prenatal exposure, on the other hand, does not seem to affect body fat percentage.

11 Jun 2022

Mid-gestational factors predict small-for-gestational age

09 Jun 2022

Risk prediction models including factors such as maternal smoking status, body mass index, and parity, can help predict small-for-gestational age (SGA) during pregnancy, a recent Japan study has found.

09 Jun 2022

Women with rheumatic diseases face adverse pregnancy outcomes

09 Jun 2022 by

Pregnancies in women with rheumatic and systemic autoimmune diseases—including systemic lupus erythematosus, spondyloarthritis, and rheumatoid arthritis—pose significant health risks and are likely to lead to unfavourable outcomes, according to several studies presented at this year’s European Alliance of Associations for Rheumatology (EULAR) Congress.

09 Jun 2022

Postpartum depression: Another outcome of the COVID-19 pandemic?

08 Jun 2022 by

Several studies presented at ACOG 2022 have raised the question as to whether postpartum depression (PPD) is one of the mental health outcomes of the COVID-19 pandemic.

08 Jun 2022

Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate

07 Jun 2022 by

A recent cross-sectional questionnaire study has shown that women with postmenopausal bleeding (PMB) would select transvaginal sonography to measure endometrial thickness (TVS-ET) over gold-standard hysteroscopy with biopsy if TVS-ET achieved a median endometrial cancer detection rate of 95.0 percent.

07 Jun 2022

SPLENDID unmasks benefits of bariatric surgery in cancer

07 Jun 2022 by

New evidence from the SPLENDID study unmasks the benefits of weight loss achieved with bariatric surgery in protecting against cancer.

07 Jun 2022

HRT use tied to reduced COVID-19 death risk

02 Jun 2022 by

The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.

02 Jun 2022

Local oestrogen of limited benefit in pelvic organ prolapse

02 Jun 2022

Locally applied oestrogen does not seem to improve sexual function in postmenopausal women with pelvic organ prolapse (POP), reports a recent study.

02 Jun 2022

Temporomandibular disorder-induced pain tied to menopausal symptoms

02 Jun 2022

Pain caused by temporomandibular disorder appears to be related to menopausal symptoms, especially among women in the late menopausal transition, a study has found.

02 Jun 2022

Ectopic pregnancies resolve in around 20 days after methotrexate treatment

31 May 2022

Methotrexate treatment helps resolve ectopic pregnancies after a median of 22 days, a recent study has found. Baseline levels of human chorionic gonadotrophin (hCG) may help predict the timing of resolution.

31 May 2022

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Prenatal phthalate exposure may stunt infant growth

Mid-gestational factors predict small-for-gestational age

Women with rheumatic diseases face adverse pregnancy outcomes

Postpartum depression: Another outcome of the COVID-19 pandemic?

Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate

SPLENDID unmasks benefits of bariatric surgery in cancer

HRT use tied to reduced COVID-19 death risk

Local oestrogen of limited benefit in pelvic organ prolapse

Temporomandibular disorder-induced pain tied to menopausal symptoms

Ectopic pregnancies resolve in around 20 days after methotrexate treatment